Eastman Chemical (EMN)
(Delayed Data from NYSE)
$100.29 USD
-2.08 (-2.03%)
Updated Sep 3, 2024 04:00 PM ET
After-Market: $99.11 -1.18 (-1.18%) 7:10 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$100.29 USD
-2.08 (-2.03%)
Updated Sep 3, 2024 04:00 PM ET
After-Market: $99.11 -1.18 (-1.18%) 7:10 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Zacks News
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Hold Onto Eastman Chemical (EMN) for Now
by Zacks Equity Research
While Eastman Chemical (EMN) faces headwinds from higher input and logistics costs, it benefits from productivity actions, strong demand and innovation.
Eastman Chemical (EMN) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
DuPont de Nemours (DD) Down 2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FMC (FMC) Down 0.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Eastman Chemical (EMN) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
This is Why Eastman Chemical (EMN) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Should Value Investors Pick Eastman Chemical (EMN) Stock?
by Zacks Equity Research
Let's see if Eastman Chemical (EMN) stock is a good choice for value-oriented investors right now from multiple angles.
Eastman (EMN) Declares Share Buyback Worth $500 Million
by Zacks Equity Research
Eastman Chemical (EMN) will complete a buyback of roughly $750 million in the second quarter with the implementation of the ASR.
Why Eastman Chemical (EMN) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman Chemical (EMN) Q1 Earnings Lag, Sales Beat Estimates
by Zacks Equity Research
Eastman Chemical (EMN) gains on innovation-driven growth model, strong end-market demand and pricing actions amid headwinds from higher raw material costs.
Eastman Chemical (EMN) Q1 Earnings Miss Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of -0.48% and 10.45%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Eastman Chemical (EMN)
by Zacks Equity Research
Eastman Chemical (EMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Chemical Stock Q1 Earnings Slated on Apr 28: EMN, CE, HUN & OLN
by Anindya Barman
Chemical companies' Q1 results are likely to have been driven by higher demand and the benefits of strategic actions amid headwinds from input cost inflation. Let's see how EMN, CE, HUN and OLN are poised ahead of their earnings releases.
Eastman Chemical (EMN) to Post Q1 Earnings: Factors at Play
by Zacks Equity Research
Eastman Chemical's (EMN) Q1 earnings are likely to have benefited from cost-management actions and revenues from innovation.
Eastman Chemical (EMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Eastman Chemical (EMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a High-Growth Dividend Stock? Eastman Chemical (EMN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Why Eastman Chemical (EMN) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why You Should Retain Eastman Chemical (EMN) in Your Portfolio
by Zacks Equity Research
While Eastman Chemical (EMN) faces headwinds from higher input costs, it benefits from productivity actions and innovation.
Why Eastman Chemical (EMN) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman (EMN) Enters Negotiation for Molecular Recycling Site
by Zacks Equity Research
Eastman Chemical's (EMN) negotiation with Port-Jerome-sur-Seine authorities is a significant step toward an important milestone in the company's plan to invest up to $1 billion.
Eastman Chemical (EMN) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Eastman Chemical (EMN) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Eastman Chemical (EMN) Gains on Cost Actions and Innovation
by Zacks Equity Research
Eastman Chemical (EMN) gains on cost-cutting and productivity actions and efforts to drive new business revenues from innovation.
Univar (UNVR) Inks Deal With Particle Dynamics, Boosts Portfolio
by Zacks Equity Research
Univar (UNVR) will provide United States and Canada customers with Particle Dynamics' compressible calcium and magnesium carbonates and microencapsulated vitamins and minerals.